WO2026056936 - HETEROCYCLIC COMPOUNDS AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/056936
Publication Date
19.03.2026
International Application No.
PCT/CN2025/120506
International Filing Date
10.09.2025
Title **
[English]
HETEROCYCLIC COMPOUNDS AND USE THEREOF
[French]
COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION
[Chinese]
一种杂环化合物及其用途
Applicants **
CHENGDU MFS PHARMA.CO., LTD.
Inventors
CHEN, guangwu
LIU, jin
ZHANG, Wensheng
ZHANG, hancheng
MA, haijun
XIE, Zhenbiao
Priority Data
202411287190.X
13.09.2024
CN
202510103258.2
22.01.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2247 | |
| EPO | Filing, Examination, Granting | 14002 | |
| Japan | Filing, Examination, Granting | 2030 | |
| South Korea | Filing, Examination, Granting | 1900 | |
| USA | Filing, Examination, Granting | 5190 |
Total:
25,369
Contact Us
Abstract[English]
Provided in the present invention are heterocyclic compounds, and a pharmaceutical composition and use thereof, belonging to the technical field of pharmaceutical chemistry. The series of heterocyclic compounds prepared by the present invention have effective sedative, hypnotic and/or anaesthetic effects, can control the status epilepticus, and also have an analgesic effect, thus providing a new option for clinical preparation of drugs having an analgesic effect, drugs having anaesthetic, sedative, or hypnotic effects and/or capable of controlling status epilepticus, and drugs having anaesthetic, sedative, or hypnotic effects and/or being capable of controlling status epilepticus and also having an analgesic effect.[French]
La présente invention concerne des composés hétérocycliques, une composition pharmaceutique et leur utilisation, appartenant au domaine technique de la chimie pharmaceutique. La série de composés hétérocycliques préparés selon la présente invention ont des effets sédatifs, hypnotiques et/ou anesthésiques efficaces, peuvent réguler l'état épileptique, et ont également un effet analgésique, offrant ainsi une nouvelle option pour la préparation clinique de médicaments ayant un effet analgésique, des médicaments ayant des effets anesthésiques, sédatifs ou hypnotiques et/ou capables de lutter contre l'état épileptique, et des médicaments ayant des effets anesthésiques, sédatifs ou hypnotiques et/ou étant capables de lutter contre l'état de mal épileptique et ayant également un effet analgésique.[Chinese]
本发明提供了一种杂环化合物及其药物组合物和用途，属于药物化学技术领域。本发明制备的一系列杂环化合物，具有高效的镇静、催眠和/或麻醉作用，能够控制癫痫持续状态，同时还具有镇痛作用，为临床上制备具有镇痛作用的药物，具有麻醉、镇静、催眠作用和/或能够控制癫痫持续状态的药物，以及既具有麻醉、镇静、催眠作用和/或能够控制癫痫持续状，同时还具有镇痛作用的药物提供了一种新的选择。